CDCA3 and renal cell carcinoma: This initially showed that there was a close relationship between CDCA3 and immune checkpoints and further suggested that CDCA3 may participate in the immune pathway of RCC by regulating immune regulatory factors, which may be a potential target for immunotherapy.